Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI

NCT00229515 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

744

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction

Interventions

OTHER: abciximab followed by implantation of bare metal stent
OTHER: abciximab and Sirolimus eluting stent
OTHER: tirofiban and bare metal stent
OTHER: tirofiban and sirolimus-eluting stent

Sponsor

Marco Valgimigli